Campbell & Co Investment Adviser’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,470
| Closed | -$202K | – | 1353 |
|
|
2024
Q3 | $202K | Sell |
6,470
-6,724
| -51% | -$210K | 0.02% | 1016 |
|
|
2024
Q2 | $353K | Buy |
+13,194
| New | +$353K | 0.03% | 774 |
|
|
2024
Q1 | – | Sell |
-26,210
| Closed | -$759K | – | 1356 |
|
|
2023
Q4 | $759K | Buy |
+26,210
| New | +$759K | 0.07% | 514 |
|
|
2022
Q4 | – | Sell |
-15,923
| Closed | -$539K | – | 993 |
|
|
2022
Q3 | $539K | Buy |
+15,923
| New | +$539K | 0.12% | 297 |
|
|
2021
Q1 | – | Sell |
-9,069
| Closed | -$228K | – | 598 |
|
|
2020
Q4 | $228K | Sell |
9,069
-2,300
| -20% | -$57.8K | 0.14% | 331 |
|
|
2020
Q3 | $237K | Buy |
11,369
+1,268
| +13% | +$26.4K | 0.18% | 264 |
|
|
2020
Q2 | $240K | Buy |
+10,101
| New | +$240K | 0.3% | 162 |
|
|
2019
Q2 | – | Sell |
-5,809
| Closed | -$204K | – | 699 |
|
|
2019
Q1 | $204K | Buy |
+5,809
| New | +$204K | 0.1% | 448 |
|
|
2016
Q4 | – | Sell |
-8,504
| Closed | -$210K | – | 191 |
|
|
2016
Q3 | $210K | Buy |
+8,504
| New | +$210K | 0.57% | 85 |
|